These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32526294)

  • 1. Early but not late conformational changes of tau in association with ubiquitination of neurofibrillary pathology in Alzheimer's disease brains.
    Ibarra-Bracamontes VJ; Escobar-Herrera J; Kristofikova Z; Rípova D; Florán-Garduño B; Garcia-Sierra F
    Brain Res; 2020 Oct; 1744():146953. PubMed ID: 32526294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease.
    Horowitz PM; Patterson KR; Guillozet-Bongaarts AL; Reynolds MR; Carroll CA; Weintraub ST; Bennett DA; Cryns VL; Berry RW; Binder LI
    J Neurosci; 2004 Sep; 24(36):7895-902. PubMed ID: 15356202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease.
    García-Sierra F; Ghoshal N; Quinn B; Berry RW; Binder LI
    J Alzheimers Dis; 2003 Apr; 5(2):65-77. PubMed ID: 12719624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease.
    Luna-Muñoz J; García-Sierra F; Falcón V; Menéndez I; Chávez-Macías L; Mena R
    J Alzheimers Dis; 2005 Sep; 8(1):29-41. PubMed ID: 16155347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin is associated with early truncation of tau protein at aspartic acid(421) during the maturation of neurofibrillary tangles in Alzheimer's disease.
    García-Sierra F; Jarero-Basulto JJ; Kristofikova Z; Majer E; Binder LI; Ripova D
    Brain Pathol; 2012 Mar; 22(2):240-50. PubMed ID: 21919991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies.
    Combs B; Hamel C; Kanaan NM
    Neurobiol Dis; 2016 Oct; 94():18-31. PubMed ID: 27260838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of α-1-Antichymotrypsin Expression with the Development of Conformational Changes of Tau Protein in Alzheimer's Disease Brain.
    Horta-López PH; Mendoza-Franco G; Rodríguez-Cruz F; Torres-Cruz FM; Hernández-Echeagaray E; Jarero-Basulto JJ; Rícny J; Florán Garduño B; Garcia-Sierra F
    Neuroscience; 2023 May; 518():83-100. PubMed ID: 35007692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease.
    Luna-Muñoz J; Chávez-Macías L; García-Sierra F; Mena R
    J Alzheimers Dis; 2007 Dec; 12(4):365-75. PubMed ID: 18198423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of aspartic acid421- and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease.
    Basurto-Islas G; Luna-Muñoz J; Guillozet-Bongaarts AL; Binder LI; Mena R; García-Sierra F
    J Neuropathol Exp Neurol; 2008 May; 67(5):470-83. PubMed ID: 18431250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease.
    Bengoa-Vergniory N; Velentza-Almpani E; Silva AM; Scott C; Vargas-Caballero M; Sastre M; Wade-Martins R; Alegre-Abarrategui J
    Acta Neuropathol Commun; 2021 Jan; 9(1):18. PubMed ID: 33509301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.
    Guillozet-Bongaarts AL; Garcia-Sierra F; Reynolds MR; Horowitz PM; Fu Y; Wang T; Cahill ME; Bigio EH; Berry RW; Binder LI
    Neurobiol Aging; 2005 Jul; 26(7):1015-22. PubMed ID: 15748781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease.
    Mondragón-Rodríguez S; Basurto-Islas G; Santa-Maria I; Mena R; Binder LI; Avila J; Smith MA; Perry G; García-Sierra F
    Int J Exp Pathol; 2008 Apr; 89(2):81-90. PubMed ID: 18336525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease.
    García-Sierra F; Wischik CM; Harrington CR; Luna-Muñoz J; Mena R
    J Chem Neuroanat; 2001 Jul; 22(1-2):65-77. PubMed ID: 11470555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research.
    Moloney CM; Lowe VJ; Murray ME
    Alzheimers Dement; 2021 Sep; 17(9):1554-1574. PubMed ID: 33797838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease.
    Ghoshal N; García-Sierra F; Wuu J; Leurgans S; Bennett DA; Berry RW; Binder LI
    Exp Neurol; 2002 Oct; 177(2):475-93. PubMed ID: 12429193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau truncation is a productive posttranslational modification of neurofibrillary degeneration in Alzheimer's disease.
    Kovacech B; Novak M
    Curr Alzheimer Res; 2010 Dec; 7(8):708-16. PubMed ID: 20678071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational change as one of the earliest alterations of tau in Alzheimer's disease.
    Weaver CL; Espinoza M; Kress Y; Davies P
    Neurobiol Aging; 2000; 21(5):719-27. PubMed ID: 11016541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual modification of Alzheimer's disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach.
    Thomas SN; Funk KE; Wan Y; Liao Z; Davies P; Kuret J; Yang AJ
    Acta Neuropathol; 2012 Jan; 123(1):105-17. PubMed ID: 22033876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation.
    Aragão Gomes L; Uytterhoeven V; Lopez-Sanmartin D; Tomé SO; Tousseyn T; Vandenberghe R; Vandenbulcke M; von Arnim CAF; Verstreken P; Thal DR
    Acta Neuropathol; 2021 Feb; 141(2):173-192. PubMed ID: 33427938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospho-Tau Changes in the Human CA1 During Alzheimer's Disease Progression.
    Regalado-Reyes M; Furcila D; Hernández F; Ávila J; DeFelipe J; León-Espinosa G
    J Alzheimers Dis; 2019; 69(1):277-288. PubMed ID: 30958368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.